Investing

By Chris Wack Atai Life Sciences saw positive results from its Phase 1 study evaluating orally administered EMP-01. The goals…

By Colin Kellaher Shares of Corcept Therapeutics tumbled more than 30% in premarket trading Tuesday after the pharmaceutical company suffered…

By Emon Reiser Alimera Sciences on Tuesday named Elliot Maltz as chief financial officer. Maltz succeeds Russell Skibsted in the…

By Colin Kellaher Retail energy-services company Via Renewables has struck a deal to be taken private by its top executive.…

Hello! This is MarketWatch reporter Isabel Wang bringing you this week’s ETF Wrap. In this week’s edition, we look at…

Don’t miss these top mutual fund and ETF investing features: Sign up here to get MarketWatch’s best mutual funds and ETF…

Hello! Stocks and bonds are heading for gains in 2023 as ETF investors show signs of “more exuberance” in December.…

Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed…

Hello! This is MarketWatch reporter Isabel Wang bringing you this week’s ETF Wrap. In this week’s edition, we look at…

Don’t miss these top mutual fund- and ETF-related features: Sign up here to get MarketWatch’s best mutual funds and ETF stories…